107 related articles for article (PubMed ID: 1797460)
1. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.
Hohl P; Frei R; Aubry P
Diagn Microbiol Infect Dis; 1991; 14(5):447-50. PubMed ID: 1797460
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
[TBL] [Abstract][Full Text] [Related]
4. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
Smit WJ; Boquest AL; Geddes JE; Tosolini FA
Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
[TBL] [Abstract][Full Text] [Related]
5. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
Vartivarian S; Anaissie E; Bodey G; Sprigg H; Rolston K
Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
9. Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia.
Carroll KC; Cohen S; Nelson R; Campbell DM; Claridge JD; Garrison MW; Kramp J; Malone C; Hoffmann M; Anderson DE
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):229-35. PubMed ID: 9884841
[TBL] [Abstract][Full Text] [Related]
10. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.
Yao JD; Louie M; Louie L; Goodfellow J; Simor AE
J Clin Microbiol; 1995 May; 33(5):1428-30. PubMed ID: 7615774
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
[TBL] [Abstract][Full Text] [Related]
12. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Ahmed A; Hafiz S; Ahmed QT; Majeed H; Syed S
J Pak Med Assoc; 1998 Jun; 48(6):158-61. PubMed ID: 9813984
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents.
Khardori N; Reuben A; Rosenbaum B; Rolston K; Bodey GP
Antimicrob Agents Chemother; 1990 Aug; 34(8):1609-10. PubMed ID: 2221872
[TBL] [Abstract][Full Text] [Related]
18. Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia.
Muñoz JL; García MI; Muñoz S; Leal S; Fajardo M; Garćia-Rodríguez JA
Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):879-82. PubMed ID: 8997563
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia.
Weiss K; Restieri C; De Carolis E; Laverdière M; Guay H
J Antimicrob Chemother; 2000 Mar; 45(3):363-5. PubMed ID: 10702558
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Ismaeel NA
Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
